Redeye: Formpipe - Further Improvements in Margins
Redeye retains its positive view of Formpipe following a Q4 report largely matching our expectations. While lowering our short- and mid-term forecasts somewhat, we find management’s positive outlook and initiatives for improved growth encouraging.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/